Iborra, Marisa
Beltrán, Belén
Maroto, Nuria
Navarro-Cortés, Pablo
Boscá-Watts, Maia
Ferrer-Bradley, Isabel
García-Morales, Natalia
Sáez-González, Esteban
Hinojosa, Joaquín
Mínguez, Miguel
Nos, Pilar
This article is maintained by: Elsevier
Article Title: Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents
Journal Title: Gastroenterología y Hepatología (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2018.11.007
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2018.06.001
Content Type: article
Copyright: © 2018 Elsevier España, S.L.U. All rights reserved.